
BioVantix is a biotechnology platform company focused on redefining biologic delivery and unlocking the full commercial and therapeutic potential of advanced medicines. The company is developing a proprietary hybrid nanoplatform, enhanced by AI-driven optimization, engineered to overcome critical limitations in stability, bioavailability, and targeted delivery. By addressing one of the most persistent bottlenecks in life sciences, BioVantix is positioned to enable higher-performing therapeutics across a wide range of high-value indications. BioVantix operates with a platform-first…
Built from contact records that share this company: name, job title, job level, job function and person location.
Turn cold outreach into meaningful business conversations.
Rated and recommended by professionals who expect more
Annual Revenue$10M to $25M
Estimated OwnershipPrivateMatching runs on fields we already have: industry, employee range, HQ location, ownership type, funding rounds, specialities. Results come live from the ReachStream directory.